Call Options

13 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Oct 25, 2022

BUY
$22.17 - $51.8 $84,246 - $196,840
3,800 Added 35.85%
14,400 $232,000
Q2 2022

Aug 04, 2022

SELL
$15.36 - $27.51 $204,288 - $365,883
-13,300 Reduced 55.65%
10,600 $78,000
Q1 2022

Apr 14, 2022

SELL
$22.22 - $39.12 $933,240 - $1.64 Million
-42,000 Reduced 63.73%
23,900 $87,000
Q4 2021

Jan 18, 2022

SELL
$18.38 - $40.5 $156,230 - $344,250
-8,500 Reduced 11.42%
65,900 $354,000
Q3 2021

Oct 26, 2021

BUY
$13.18 - $19.83 $213,516 - $321,246
16,200 Added 27.84%
74,400 $331,000
Q2 2021

Jul 19, 2021

BUY
$9.59 - $50.88 $555,261 - $2.95 Million
57,900 Added 19300.0%
58,200 $129,000
Q1 2021

Apr 26, 2021

SELL
$49.53 - $68.4 $168,402 - $232,560
-3,400 Reduced 91.89%
300 $1,000
Q4 2020

Jan 21, 2021

SELL
$47.25 - $65.16 $103,950 - $143,352
-2,200 Reduced 37.29%
3,700 $17,000
Q3 2020

Oct 27, 2020

BUY
$46.35 - $61.69 $101,970 - $135,718
2,200 Added 59.46%
5,900 $31,000
Q2 2020

Jul 22, 2020

SELL
$38.58 - $65.07 $88,734 - $149,660
-2,300 Reduced 38.33%
3,700 $28,000
Q1 2020

May 07, 2020

BUY
$32.73 - $50.78 $196,379 - $304,680
6,000 New
6,000 $29,000
Q4 2018

Feb 05, 2019

SELL
$9.15 - $12.26 $9,150 - $12,260
-1,000 Closed
0 $0
Q3 2018

Nov 07, 2018

BUY
$10.49 - $13.72 $10,490 - $13,720
1,000 New
1,000 $2,000

Others Institutions Holding CCXI

About ChemoCentryx, Inc.


  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.